Sierra Oncology (SRRA) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 31 253 sessions, June 30, 2021 to June 30, 2022
- Largest daily move
- +46.2% close of January 25, 2022
- 1-year change
- +182.4% closing prices, June 30, 2021 to June 30, 2022
- 1-month change
- +0.4% closing prices, May 27, 2022 to June 30, 2022
Company Description
Sierra Oncology (NASDAQ: SRRA) is classified in the biotechnology industry within the Healthcare sector.
SRRA gained 182.4% in the 12 months to June 30, 2022. The last closing price was $54.99.
This page collects what Stock Titan holds for SRRA, including price data and latest news.
Stock Performance
Sierra Oncology (SRRA) closed at $54.99 on June 30, 2022. In the 12 months to June 30, 2022, the price gained 182.4%.
SRRA Metrics & Rankings
Price returns through June 30, 2022. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Sierra Oncology has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include clinical trial, earnings, management, acquisition, conferences. View all SRRA news →
SEC Filings
SRRA Company Profile & Sector Positioning
Sierra Oncology (SRRA) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing SRRA often look at related companies in the same sector, including Rapport Therapeutics, Inc. (RAPP), Lycia Therapeutics, Inc. (LYCA), Korsana Biosciences, Inc. (KRSA), Ascentage Pharma Group International (AAPG), and Taysha Gene Therapies, Inc. (TSHA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SRRA's relative position within its industry.